Category: Approval/Launch Region: North America · United States Company: Bavarian Nordic Inc

Bavarian Nordic Receives European Approval of Extension of Vaccine Label to Include Monkeypox

Bavarian Nordic Receives European Approval of Extension of Vaccine Label to Include Monkeypox
Bavarian Nordic A/S (OMX: BAVA) announced today that the European Commission (EC) has extended the marketing authorization for the Company

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!